Pranlukast regulates tumour growth by attenuating IL-4 production in Kimura disease

Eur J Pediatr. 2004 Jul;163(7):416-7. doi: 10.1007/s00431-004-1441-x. Epub 2004 Apr 16.

Authors

Yoshikazu Ohtsuka¹, Toshiaki Shimizu, Tohru Fujii, Tetsuji Sato, Masahiro Saito, Satoru Nagata, Hiroshi Takahashi, Yuichiro Yamashiro

Affiliation

¹ Department of Paediatrics, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, 113-8421 Tokyo, Japan. [email protected]

PMID: 15088141
DOI: 10.1007/s00431-004-1441-x

No abstract available

Publication types

Case Reports

MeSH terms

Adolescent
Angiolymphoid Hyperplasia with Eosinophilia / blood
Angiolymphoid Hyperplasia with Eosinophilia / drug therapy*
Child
Chromones / therapeutic use*
Enzyme-Linked Immunosorbent Assay
Humans
Interleukin-4 / blood*
Leukotriene Antagonists / therapeutic use
Male
Treatment Outcome

Substances

Chromones
Leukotriene Antagonists
Interleukin-4
pranlukast